Stelvio Oncology's Seed Round

Stelvio Oncology raised a round of funding on September 12, 2017. Investors include IndieBio.

Stelvio Oncology is developing an epigenetic signature based platform for identifying compounds that drive the differentiation of cancer stem cells into benign cell types.…

Articles about Stelvio Oncology's Seed Round: